Nature Communications (Nov 2023)

Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment

  • Ning Li,
  • Qin Zhu,
  • Yuhua Tian,
  • Kyung Jin Ahn,
  • Xin Wang,
  • Zvi Cramer,
  • Justine Jou,
  • Ian W. Folkert,
  • Pengfei Yu,
  • Stephanie Adams-Tzivelekidis,
  • Priyanka Sehgal,
  • Najia N. Mahmoud,
  • Cary B. Aarons,
  • Robert E. Roses,
  • Andrei Thomas-Tikhonenko,
  • Emma E. Furth,
  • Ben Z. Stanger,
  • Anil Rustgi,
  • Malay Haldar,
  • Bryson W. Katona,
  • Kai Tan,
  • Christopher J. Lengner

DOI
https://doi.org/10.1038/s41467-023-43746-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Abstract The initiation and progression of cancer are intricately linked to the tumor microenvironment (TME). Understanding the function of specific cancer-TME interactions poses a major challenge due in part to the complexity of the in vivo microenvironment. Here we predict cancer-TME interactions from single cell transcriptomic maps of both human colorectal cancers (CRCs) and mouse CRC models, ask how these interactions are altered in human tumor organoid (tumoroid) cultures, and functionally recapitulate human myeloid-carcinoma interactions in vitro. Tumoroid cultures suppress gene expression programs involved in inflammation and immune cell migration, providing a reductive platform for re-establishing carcinoma-immune cell interactions in vitro. Introduction of human monocyte-derived macrophages into tumoroid cultures instructs macrophages to acquire immunosuppressive and pro-tumorigenic gene expression programs similar to those observed in vivo. This includes hallmark induction of SPP1, encoding Osteopontin, an extracellular CD44 ligand with established oncogenic effects. Taken together, these findings offer a framework for understanding CRC-TME interactions and provide a reductionist tool for modeling specific aspects of these interactions.